Enanta Pharmaceuticals ENTA Q2 2025 earnings
Reported August 11, 2025 · Before market open
Revenue$18.3MBeat by $2.3M
EPS-$0.85Beat by $0.40
Revenue estimate$16.0M
EPS estimate-$1.25
Next report
Aug 10, 2026 (In 1 week)Revenue estimate$16.8M
EPS estimate-$0.51
Versus estimates
Revenue
Diluted EPS
Ask the moment Enanta Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Enanta Pharmaceuticals report Q2 2025 earnings?
- Enanta Pharmaceuticals (ENTA) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Enanta Pharmaceuticals's Q2 2025 revenue and EPS?
- Enanta Pharmaceuticals reported revenue of $18.3M and eps of $-0.85 for Q2 2025.
- Did Enanta Pharmaceuticals beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $16.0M by $2.3M. EPS beat the consensus estimate of $-1.25 by $0.40.
- How did Enanta Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 1.9% from $18.0M a year earlier and eps grew 20.6% from $-1.07.
- Where can I find Enanta Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-179795) directly on SEC EDGAR. The filing index links above go to sec.gov.